Related references
Note: Only part of the references are listed.The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China
David S. Hui et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
Camilla Rothe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection
Hyoung-Shik Shin et al.
CLINICAL INFECTIOUS DISEASES (2019)
Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset
Emmie de Wit et al.
ANTIVIRAL RESEARCH (2019)
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Alexandra C. Walls et al.
CELL (2019)
Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis
Niels C. Pedersen et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2019)
A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model
Anwar M. Hashem et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas
Danielle R. Adney et al.
VIRUSES-BASEL (2019)
Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs
Benjamin Strobel et al.
HUMAN GENE THERAPY METHODS (2019)
Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar
Reham A. Al Kahlout et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development
Ayman Mubarak et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Diagnostic delays in Middle East respiratory syndrome coronavirus patients and health systems
Anwar E. Ahmed
JOURNAL OF INFECTION AND PUBLIC HEALTH (2019)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
Rudragouda Channappanavar et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
Kayvon Modjarrad et al.
LANCET INFECTIOUS DISEASES (2019)
Protective Efficacy of Nucleic Acid Vaccines Against Transmission of Zika Virus During Pregnancy in Mice
Brett W. Jagger et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD
Nianshuang Wang et al.
CELL REPORTS (2019)
Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus
Chean Yeah Yong et al.
FRONTIERS IN MICROBIOLOGY (2019)
Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism
Craig Schindewolf et al.
VIRUSES-BASEL (2019)
SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target
Shuofeng Yuan et al.
NATURE COMMUNICATIONS (2019)
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
Jiuyang Xu et al.
EMERGING MICROBES & INFECTIONS (2019)
Advances in mRNA Vaccines for Infectious Diseases
Cuiling Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA
Francois Ferron et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets
Emmie de Wit et al.
ANTIVIRAL RESEARCH (2018)
Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience
Jae-Hoon Ko et al.
ANTIVIRAL THERAPY (2018)
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
Mun Peak Nyon et al.
VACCINE (2018)
The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies
B. G. Murphy et al.
VETERINARY MICROBIOLOGY (2018)
Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells
Jean Kaoru Millet et al.
VIROLOGY (2018)
Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model
Bianca S. Bodmer et al.
VIROLOGY (2018)
Chaperna-Mediated Assembly of Ferritin-Based Middle East Respiratory Syndrome-Coronavirus Nanoparticles
Young-Seok Kim et al.
FRONTIERS IN IMMUNOLOGY (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Giving the Genes a Shuffle: Using Natural Variation to Uncerstanc Host Genetic Contrioutions to Viral Infections
Sarah R. Leist et al.
TRENDS IN GENETICS (2018)
Chimeric camel/human heavy-chain antibodies protect against MERS-CoV infection
V. Stalin Raj et al.
SCIENCE ADVANCES (2018)
Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
Nick S. Laursen et al.
SCIENCE (2018)
How will the field of gene therapy survive its success?
William F. Kaemmerer
BIOENGINEERING & TRANSLATIONAL MEDICINE (2018)
One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus
Christoph Wirblich et al.
JOURNAL OF VIROLOGY (2017)
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
Rudragouda Channappanavar et al.
JOURNAL OF IMMUNOLOGY (2017)
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion
Longping Victor Tse et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
Naif Khalaf Alharbi et al.
VACCINE (2017)
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Lan Jiaming et al.
VACCINE (2017)
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
Christopher M. Coleman et al.
VACCINE (2017)
DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice
Hang Chi et al.
VACCINE (2017)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein
Sawsan S. Al-amri et al.
SCIENTIFIC REPORTS (2017)
Ongoing developments in RSV prophylaxis: a clinician's analysis
Fariba Rezaee et al.
CURRENT OPINION IN VIROLOGY (2017)
Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection
Yufei Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Michael K. Lo et al.
SCIENTIFIC REPORTS (2017)
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
Neeltje van Doremalen et al.
ANTIVIRAL RESEARCH (2017)
MERS-coronavirus: From discovery to intervention
W. Widagdo et al.
ONE HEALTH (2017)
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors
Vathan Kumar et al.
ANTIVIRAL RESEARCH (2017)
Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice
Chong Wang et al.
ANTIVIRAL RESEARCH (2017)
Modified mRNA Vaccines Protect against Zika Virus Infection
Justin M. Richner et al.
CELL (2017)
Combination therapy with lopinavir/ritonavir, ribavirin and interferon-alpha for Middle East respiratory syndrome
Uh Jin Kim et al.
ANTIVIRAL THERAPY (2016)
Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
Naru Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection
Victor M. Corman et al.
CLINICAL INFECTIOUS DISEASES (2016)
An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels
Bart L. Haagmans et al.
SCIENCE (2016)
Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection
Hongjie Qiu et al.
ANTIVIRAL RESEARCH (2016)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Jincun Zhao et al.
IMMUNITY (2016)
Middle East respiratory syndrome vaccines
Stanley Perlman et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2016)
A review of treatment modalities for Middle East Respiratory Syndrome
Yin Mo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
Katherine V. Houser et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection
Maria P. Limberis et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Pre-fusion structure of a human coronavirus spike protein
Robert N. Kirchdoerfer et al.
NATURE (2016)
Coronaviruses - drug discovery and therapeutic options
Alimuddin Zumla et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
SARS and MERS: recent insights into emerging coronaviruses
Emmie de Wit et al.
NATURE REVIEWS MICROBIOLOGY (2016)
SARS-like WIV1-CoV poised for human emergence
Vineet D. Menachery et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
Reed F. Johnson et al.
VIROLOGY (2016)
A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection
Wanbo Tai et al.
VIROLOGY (2016)
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus
Anurodh Shankar Agrawal et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome
Davide Corti et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
George M. Warimwe et al.
SCIENTIFIC REPORTS (2016)
Ribavirin: Past, present and future
Veronique Loustaud-Ratti et al.
WORLD JOURNAL OF HEPATOLOGY (2016)
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Daniel C. Payne et al.
EMERGING INFECTIOUS DISEASES (2016)
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Yaseen M. Arabi et al.
EMERGING INFECTIOUS DISEASES (2016)
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Yan Li et al.
CELL RESEARCH (2015)
Middle East respiratory syndrome: current status and future prospects for vaccine development
Lanying Du et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Strategies to circumvent humoral immunity to adeno-associated viral vectors
Longping V. Tse et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus
Xiaojuan Guo et al.
IMMUNOLOGY (2015)
IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
Sarah Shalhoub et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection
Rudragouda Channappanavar et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
Jasper Fuk-Woo Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform
Anna H. Malczyk et al.
JOURNAL OF VIROLOGY (2015)
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
Vineet D. Menachery et al.
NATURE MEDICINE (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates
Karuppiah Muthumani et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
Jean Kaoru Millet et al.
VIRUS RESEARCH (2015)
Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
Olivier Reynard et al.
VIRUSES-BASEL (2015)
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
Tianlei Ying et al.
NATURE COMMUNICATIONS (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
History of passive antibody administration for prevention and treatment of infectious diseases
Barney S. Graham et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus
Jian Tang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Recombinant Receptor Binding Domain Protein Induces Partial Protective Immunity in Rhesus Macaques Against Middle East Respiratory Syndrome Coronavirus Challenge
Jiaming Lan et al.
EBIOMEDICINE (2015)
Ribavirin and interferon-alpha 2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases
Mohammed Khalid et al.
ANTIVIRAL THERAPY (2015)
Inhibition of Proprotein Convertases Abrogates Processing of the Middle Eastern Respiratory Syndrome Coronavirus Spike Protein in Infected Cells but Does Not Reduce Viral Infectivity
Stefanie Gierer et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Molecular pathology of emerging coronavirus infections
Lisa E. Gralinski et al.
JOURNAL OF PATHOLOGY (2015)
Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia
Mohammad Khalid et al.
ANNALS OF SAUDI MEDICINE (2014)
Biomarkers in acute respiratory distress syndrome
Alexandra Binnie et al.
CURRENT OPINION IN CRITICAL CARE (2014)
Current advancements and potential strategies in the development of MERS-CoV vaccines
Naru Zhang et al.
EXPERT REVIEW OF VACCINES (2014)
T cell-mediated immune response to respiratory coronaviruses
Rudragouda Channappanavar et al.
IMMUNOLOGIC RESEARCH (2014)
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
Jaffar A. Al-Tawfiq et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
Sudhakar Agnihothram et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
Lanying Du et al.
JOURNAL OF VIROLOGY (2014)
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study
Ali S. Omrani et al.
LANCET INFECTIOUS DISEASES (2014)
Tailoring Subunit Vaccine Immunity with Adjuvant Combinations and Delivery Routes Using the Middle East Respiratory Coronavirus (MERS-CoV) Receptor-Binding Domain as an Antigen
Jiaming Lan et al.
PLOS ONE (2014)
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein
Jean Kaoru Millet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
Xian-Chun Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
Liwei Jiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/c mice
Eun Kim et al.
VACCINE (2014)
Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments-The importance of immunofocusing in subunit vaccine design
Cuiqing Ma et al.
VACCINE (2014)
Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines
Cuiqing Ma et al.
VACCINE (2014)
Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice
Christopher M. Coleman et al.
VACCINE (2014)
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu Lu et al.
NATURE COMMUNICATIONS (2014)
MERS: emergence of a novel human coronavirus
V. Stalin Raj et al.
CURRENT OPINION IN VIROLOGY (2014)
Emergence of MERS-CoV in the Middle East: Origins, Transmission, Treatment, and Perspectives
Ahmad Sharif-Yakan et al.
PLOS PATHOGENS (2014)
AAV vectors vaccines against infectious diseases
Karen Nieto et al.
FRONTIERS IN IMMUNOLOGY (2014)
The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health
Ibrahim G. Alghamdi et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2014)
Epidemiological and clinical features of human coronavirus infections among different subsets of patients
Tatiane K. Cabeca et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS-CoV therapy
Hisham Momattin et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2013)
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Jasper F. W. Chan et al.
JOURNAL OF INFECTION (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Broad protection against influenza infection by vectored immunoprophylaxis in mice
Alejandro B. Balazs et al.
NATURE BIOTECHNOLOGY (2013)
Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques
Darryl Falzarano et al.
NATURE MEDICINE (2013)
A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
Lanying Du et al.
PLOS ONE (2013)
A Correction to the Research Article Titled: "Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza" by M. P. Limberis, V. S. Adam, G. Wong, J. Gren, D. Kobasa, T. M. Ross, G. P. Koblinger, A. Tretiakova, J. M. Wilson
Science Translational Medicine (2013)
Inhibition of novel β coronavirus replication by a combination of interferon- α2b and ribavirin
Darryl Falzarano et al.
SCIENTIFIC REPORTS (2013)
Reservoirs and vectors of emerging viruses
John S. Mackenzie et al.
CURRENT OPINION IN VIROLOGY (2013)
Viral surveillance and discovery
Walter Ian Lipkin et al.
CURRENT OPINION IN VIROLOGY (2013)
Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
Everett Clinton Smith et al.
PLOS PATHOGENS (2013)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease
Rachel L. Graham et al.
NATURE MEDICINE (2012)
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques
Gene Garrard Olinger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
Melissa M. Coughlin et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Successful Treatment of Ebola Virus-Infected Cynomolgus Macaques with Monoclonal Antibodies
Xiangguo Qiu et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein
Sandrine Belouzard et al.
VIRUSES-BASEL (2012)
Understanding the T cell immune response in SARS coronavirus infection
Hsueh-Ling Janice Oh et al.
EMERGING MICROBES & INFECTIONS (2012)
Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study
Fang Tang et al.
JOURNAL OF IMMUNOLOGY (2011)
Coronaviruses An RNA proofreading machine regulates replication fidelity and diversity
Mark R. Denison et al.
RNA BIOLOGY (2011)
Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV
Ye V. Liu et al.
VACCINE (2011)
SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission
Meagan Bolles et al.
CURRENT OPINION IN VIROLOGY (2011)
Coronaviruses Hijack the LC3-I-Positive EDEMosomes, ER-Derived Vesicles Exporting Short-Lived ERAD Regulators, for Replication
Fulvio Reggiori et al.
CELL HOST & MICROBE (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses
Siegfried Hapfelmeier et al.
SCIENCE (2010)
Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine
Anjeanette Roberts et al.
VIRAL IMMUNOLOGY (2010)
A 219-mer CHO-Expressing Receptor-Binding Domain of SARS-CoV S Protein Induces Potent Immune Responses and Protective Immunity
Lanying Du et al.
VIRAL IMMUNOLOGY (2010)
Quasispecies Theory and the Behavior of RNA Viruses
Adam S. Lauring et al.
PLOS PATHOGENS (2010)
Infidelity of SARS-CoV Nsp14-Exonuclease Mutant Virus Replication Is Revealed by Complete Genome Sequencing
Lance D. Eckerle et al.
PLOS PATHOGENS (2010)
Coronavirus Diversity, Phylogeny and Interspecies Jumping
Patrick C. Y. Woo et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Potent human monoclonal antibodies against SARS CoV, Nipah and Hendra viruses
Ponraj Prabakaran et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Transduction Efficiencies of Novel AAV Vectors in Mouse Airway Epithelium In Vivo and Human Ciliated Airway Epithelium In Vitro
Maria P. Limberis et al.
MOLECULAR THERAPY (2009)
Generation of Novel AAV Variants by Directed Evolution for Improved CFTR Delivery to Human Ciliated Airway Epithelium
Wuping Li et al.
MOLECULAR THERAPY (2009)
Coronaviruses post-SARS: update on replication and pathogenesis
Stanley Perlman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Directed evolution of adeno-associated virus to an infectious respiratory virus
Katherine J. D. A. Excoffon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites
Sandrine Belouzard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection
Lanying Du et al.
JOURNAL OF IMMUNOLOGY (2008)
Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV
Kumari G. Lokugamage et al.
VACCINE (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
Intranasal Protollin-formulated recombinant SARS S-protein elicits respiratory and serum neutralizing antibodies and protection in mice
Mary C. Hu et al.
VACCINE (2007)
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhongyu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques
Gary P. Kobinger et al.
VACCINE (2007)
The intracellular sites of early replication and budding of SARS-coronavirus
Silke Stertz et al.
VIROLOGY (2007)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin
Dale L. Barnard et al.
ANTIVIRAL RESEARCH (2006)
Human monoclonal antibody combination against SARS coronavirus: Synergy and coverage of escape mutants
Jan ter Meulen et al.
PLOS MEDICINE (2006)
Angiotensin-converting enzyme II in the heart and the kidney
U Danilczyk et al.
CIRCULATION RESEARCH (2006)
A double-inactivated whole virus candidate SARS coronavirus vaccine
M Spruth et al.
VACCINE (2006)
Protein sensors for membrane sterols
JL Goldstein et al.
CELL (2006)
Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia
PCY Woo et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Bats are natural reservoirs of SARS-like coronaviruses
WD Li et al.
SCIENCE (2005)
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine
SU Kapadia et al.
VIROLOGY (2005)
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
G Simmons et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
SARS vaccine protective in mice
K Stadler et al.
EMERGING INFECTIOUS DISEASES (2005)
Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein
H Bisht et al.
VIROLOGY (2005)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
TC Greenough et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus
EN van den Brink et al.
JOURNAL OF VIROLOGY (2005)
Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus
C Drosten et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs
ELC Tan et al.
EMERGING INFECTIOUS DISEASES (2004)
Severe acute respiratory syndrome related coronavirus is inhibited by interferon-α
U Ströher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China
JF He et al.
SCIENCE (2004)
Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques
BL Haagmans et al.
NATURE MEDICINE (2004)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association
JH Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Do men have a higher case fatality rate of severe acute respiratory syndrome than women do?
J Karlberg et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Small molecules targeting severe acute respiratory syndrome human coronavirus
CY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Structure-based discovery of a novel angiotensin converting enzyme 2 inhibitor
MJ Huentelman et al.
HYPERTENSION (2004)
Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus
PR Hsueh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
UJ Buchholz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS
A Bukreyev et al.
LANCET (2004)
Severe acute respiratory syndrome: report of treatment and outcome after a major outbreak
JJY Sung et al.
THORAX (2004)
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome - A preliminary study
MR Loutfy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
WH Li et al.
NATURE (2003)
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
YQ Ding et al.
JOURNAL OF PATHOLOGY (2003)
Virus-encoded proteinases and proteolytic processing in the Nidovirales
J Ziebuhr et al.
JOURNAL OF GENERAL VIROLOGY (2000)
Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer
J Zabner et al.
JOURNAL OF VIROLOGY (2000)
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
RB Belshe et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
Share Paper
